Libtayo is an intravenous immuno-oncology drug that harnesses the power of the body’s own immune system to fight cancer. It works by targeting PD-1, a protein found in immune cells that normally controls the immune system. Tumors that express PD-1 bind to T cells, turning off the cells’ ability to attack the tumor.
Active ingredient: Cemiplimab
Prescription medicine
Storage temperature 2-8 degrees